Skip to main content

Site notifications

CANAKINUMAB NOVARTIS canakinumab (rmc) 150mg/1mL solution for injection in pre-filled syringe Cancelled under Section 30(1)(c) of the Act

Product name
CANAKINUMAB NOVARTIS canakinumab (rmc) 150mg/1mL solution for injection in pre-filled syringe
ARTG
301195
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act

Help us improve the Therapeutic Goods Administration site